The Institute for Research on Cancer and Aging Nice (IRCAN UMR7284, U1081; https://www.ircan.org) was created in 2012, by the University Côte d’Azur (UCA), the National Institute for Health and Medical Research (Inserm), and the National Center for Scientific Research (CNRS). The IRCAN was established to develop a research program focusing on cancer and aging at the University-Hospital Campus “Pasteur” located in the Cimiez hill of Nice. IRCAN is currently composed of 14 teams that are actively working in basic as well as translational research domains, in close partnership with on-site clinical institutions, i.e. the cancer “Center Antoine Lacassagne” (CAL) and the Nice University Hospital (CHUN).
The IRCAN research program includes major areas of biology, from basic research to medical applications, with the objectives of improving our understanding of the biology of aging and of the mechanisms of cancer and age-related pathologies including neurodegenerative diseases, with the ambition to develop innovative strategies to prevent and cure these diseases. Chromosome stability, (epi)genomics, regeneration, mitochondrial dysfunction, cellular microenvironment and the environmental determinants of aging constitute the major current research axes in IRCAN. State-of-the-art core facilities (molecular and cellular imaging, flow cytometry, ‘omics’ technologies, aquatic and mouse facilities, histology etc..) are major assets for IRCAN teams, and also provide a support hub to many other public and private research laboratories. In addition, the management board of IRCAN provides efficient administrative, financial and technical support services and advises to the research teams and core facilities.
The IRCAN opens 2 positions for outstanding scientists with extensive international experience.
- Director position
Pr Eric Gilson will step down as IRCAN director on the 1st of January 2023. The next director will be an internationally recognized scientist. She/he will define an ambitious scientific strategy for IRCAN in the field of aging and cancer, both at national and international levels; she/he will play a major management role and will make decisions, assisted by an external Scientific Advisory Board and the Laboratory council of IRCAN, regarding team recruitment, scientific policy and budget.
In addition to her/his director position, the recruited scientist will run an ambitious research program in the field of aging and cancer, with no particular thematic required. Appropriate laboratory space will be available to the selected scientist.
The candidates must meet criteria to compete for national and international research funding; those who do not have a permanent position in France will have to apply to the ERC and/or to French institutional research/teaching positions (CNRS, INSERM, UCA). As a seeding funding, there is the possibility to apply for a chair of excellence (Labex Signalife) with a starting package and PI salary for one year.
Her/his mission will start on the 1st of January 2021 in order to prepare the next 2023-2027 5-year term contract of IRCAN.